Filtros : "Pharmaceutics" "FCF-FBF" Removido: "2019" Limpar

Filtros



Refine with date range


  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 27 jul. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 27 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 27 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Source: Pharmaceutics. Unidade: FCF

    Assunto: PLANEJAMENTO DE FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEON, Rosmery Merma et al. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, v. 15, p. 1-20 art. 1735, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15061735. Acesso em: 27 jul. 2024.
    • APA

      Leon, R. M., Issa, M. G., Duque, M. D., Daniel, J. S. P., & Ferraz, H. G. (2023). Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, 15, 1-20 art. 1735. doi:10.3390/pharmaceutics15061735
    • NLM

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
    • Vancouver

      Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ÓLEOS ESSENCIAIS, COMPOSTOS VOLÁTEIS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BELEM, Bruna Rodrigues et al. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, v. 15, p. 1-23 art. 2564, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112564. Acesso em: 27 jul. 2024.
    • APA

      Belem, B. R., Carapeto, G. V., Issa, M. G., & Ferraz, H. G. (2023). Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene. Pharmaceutics, 15, 1-23 art. 2564. doi:10.3390/pharmaceutics15112564
    • NLM

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 jul. 27 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
    • Vancouver

      Belem BR, Carapeto GV, Issa MG, Ferraz HG. Microemulsions: an encapsulation strategy to increase the thermal stability of D-limonene [Internet]. Pharmaceutics. 2023 ; 15 1-23 art. 2564.[citado 2024 jul. 27 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112564
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 27 jul. 2024.
    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532
    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 jul. 27 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 jul. 27 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARAPETO, Gustavo Vaiano et al. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, v. 15, p. 1-14 art. 1544, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051544. Acesso em: 27 jul. 2024.
    • APA

      Carapeto, G. V., Duque, M. D., Issa, M. G., & Ferraz, H. G. (2023). Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, 15, 1-14 art. 1544. doi:10.3390/pharmaceutics15051544
    • NLM

      Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
    • Vancouver

      Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
  • Source: Pharmaceutics. Unidades: FCF, ICB

    Subjects: INFECÇÕES OCULARES, ANTIBIÓTICOS, CONJUNTIVITE VIRAL, NANOTECNOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JESUS, José Izo Santana da Silva de et al. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, v. 14, p. 1-21 art. 2221, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14102221. Acesso em: 27 jul. 2024.
    • APA

      Jesus, J. I. S. da S. de, Lourenço, F. R., Ishida, K., Barreto, T. L., Avino, V. C., Santos Neto, E. dos, & Bou-Chacra, N. A. (2022). Besifloxacin nanocrystal: towards an innovative ophthalmic preparation. Pharmaceutics, 14, 1-21 art. 2221. doi:10.3390/pharmaceutics14102221
    • NLM

      Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
    • Vancouver

      Jesus JIS da S de, Lourenço FR, Ishida K, Barreto TL, Avino VC, Santos Neto E dos, Bou-Chacra NA. Besifloxacin nanocrystal: towards an innovative ophthalmic preparation [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 2221.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics14102221
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, MEDICAMENTO, BIOEQUIVALÊNCIA, FORMAS FARMACÊUTICAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ISSA, Michele Georges et al. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, v. 14, p. 1-21 art. 892, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14050892. Acesso em: 27 jul. 2024.
    • APA

      Issa, M. G., Souza, N. V. de, Jou, B. W. C., Duque, M. D., & Ferraz, H. G. (2022). Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling. Pharmaceutics, 14, 1-21 art. 892. doi:10.3390/pharmaceutics14050892
    • NLM

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
    • Vancouver

      Issa MG, Souza NV de, Jou BWC, Duque MD, Ferraz HG. Development of extended-release mini-tablets containing metoprolol supported by design of experiments and physiologically based biopharmaceutics modeling [Internet]. Pharmaceutics. 2022 ; 14 1-21 art. 892.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics14050892
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, v. 12, p. 1-17 art, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12050420. Acesso em: 27 jul. 2024.
    • APA

      Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2020). Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, 12, 1-17 art. doi:10.3390/pharmaceutics12050420
    • NLM

      Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
    • Vancouver

      Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: BAGAÇOS, UVA, FENÓIS, FILTRO SOLAR, ENSAIO CLÍNICO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HÜBNER, Alexandra de Almeida et al. Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking. Pharmaceutics, v. 12, p. 1-22 art. 1148, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12121148. Acesso em: 27 jul. 2024.
    • APA

      Hübner, A. de A., Sarruf, F. D., Oliveira, C. A., Neto, A. V., Fischer, D. C. H., Kato, E. T. M., et al. (2020). Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking. Pharmaceutics, 12, 1-22 art. 1148. doi:10.3390/pharmaceutics12121148
    • NLM

      Hübner A de A, Sarruf FD, Oliveira CA, Neto AV, Fischer DCH, Kato ETM, Lourenço FR, Baby AR, Bacchi EM. Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking [Internet]. Pharmaceutics. 2020 ; 12 1-22 art. 1148.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics12121148
    • Vancouver

      Hübner A de A, Sarruf FD, Oliveira CA, Neto AV, Fischer DCH, Kato ETM, Lourenço FR, Baby AR, Bacchi EM. Safety and potoprotective efficacy of a sunscreen system based on grape pomace (Vitis vinifera L.) phenolics from winemaking [Internet]. Pharmaceutics. 2020 ; 12 1-22 art. 1148.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics12121148
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: MACROMOLÉCULA, NANOCOMPOSITOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GONZAGA, Rodrigo Vieira et al. Targeting groups employed in selective dendrons and dendrimers. Pharmaceutics, v. 10, n. 4, p. 1-27 art. 219, 2018Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics10040219. Acesso em: 27 jul. 2024.
    • APA

      Gonzaga, R. V., Santos, S. da S., Silva, J. V. da, Prieto, D. C., Savino, D. F., Giarolla, J., & Ferreira, E. I. (2018). Targeting groups employed in selective dendrons and dendrimers. Pharmaceutics, 10( 4), 1-27 art. 219. doi:10.3390/pharmaceutics10040219
    • NLM

      Gonzaga RV, Santos S da S, Silva JV da, Prieto DC, Savino DF, Giarolla J, Ferreira EI. Targeting groups employed in selective dendrons and dendrimers [Internet]. Pharmaceutics. 2018 ; 10( 4): 1-27 art. 219.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics10040219
    • Vancouver

      Gonzaga RV, Santos S da S, Silva JV da, Prieto DC, Savino DF, Giarolla J, Ferreira EI. Targeting groups employed in selective dendrons and dendrimers [Internet]. Pharmaceutics. 2018 ; 10( 4): 1-27 art. 219.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics10040219
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: LÍQUIDOS IÔNICOS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAPARICA, Rita et al. Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility. Pharmaceutics, v. 10, n. 4, p. 2-13 art. 288, 2018Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics10040288. Acesso em: 27 jul. 2024.
    • APA

      Caparica, R., Júlio, A., Baby, A. R., Araújo, M. E. M., Fernandes, A. S., Costa, J. G., & Almeida, T. S. de. (2018). Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility. Pharmaceutics, 10( 4), 2-13 art. 288. doi:10.3390/pharmaceutics10040288
    • NLM

      Caparica R, Júlio A, Baby AR, Araújo MEM, Fernandes AS, Costa JG, Almeida TS de. Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility [Internet]. Pharmaceutics. 2018 ; 10( 4): 2-13 art. 288.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics10040288
    • Vancouver

      Caparica R, Júlio A, Baby AR, Araújo MEM, Fernandes AS, Costa JG, Almeida TS de. Choline-amino acid ionic liquids as green functional excipients to enhance drug solubility [Internet]. Pharmaceutics. 2018 ; 10( 4): 2-13 art. 288.[citado 2024 jul. 27 ] Available from: https://doi.org/10.3390/pharmaceutics10040288

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024